Dear Colleagues,

We are pleased to announce the “Antibodies 2024 Best Paper Award” for research and review articles published in Antibodies from 1 January 2022 to 31 December 2022. The paper will be selected after thorough evaluation by the journal Award Committee led by the EiCs, and the winner will be announced on 31 July 2024.

Eligibility for the awards:
– Papers published in Antibodies from 1 January 2022 to 31 December 2022;
– Open to all career levels;
– Both regular and Special Issue submissions will be considered.

Selection Criteria:
The papers will be selected by the journal Award Committee according to the following criteria (data source: Web of Science (Clarivate Analytics)):
– Scientific merit and broad impact;
– Relevance to the journal’s field;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citation and download rates in 2023.

Prizes:
– One review/research article award: CHF 500 and a chance to publish a paper free of charge in Antibodies before 30 December 2025;
– The winner will also receive a certificate.

The winner will be announced on the journal website on 31 July 2024.

Kind regards,
Antibodies Editorial Office

Dear Colleagues,

We are pleased to announce the winner of the Antibodies 2023 Best Paper Award. All papers published from 1 January 2021 to 31 December 2021 in Antibodies were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, one paper was selected.

Paper Title: “HDX-MS for Epitope Characterization of a Therapeutic ANTIBODY Candidate on the Calcium-Binding Protein Annexin-A1”
By Marius Gramlich, Henry C. W. Hays, Scott Crichton, Philipp D. Kaiser, Anne Heine, Nicole Schneiderhan-Marra, Ulrich Rothbauer, Dieter Stoll, Sandra Maier and Anne Zeck
Antibodies 2021, 10(1), 11; doi:10.3390/antib10010011

The winner will receive CHF 500 and a chance to publish a paper in Antibodies before 30 December 2024 after peer review.

Please join us in congratulating the winners of Antibodies 2023 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Antibodies.

Kind regards,
Antibodies Editorial Office

Dear Colleagues,

We are pleased to announce the winner of the Antibodies 2022 Best Paper Award. All papers published from 1 January 2020 to 31 December 2020 in Antibodies were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, the winning paper, which was nominated by the Editor-in-Chief Prof. Dr. Arne Skerra, has been selected.

Antibody Conjugates-Recent Advances and Future Innovations
By Donmienne Leung, Jacqueline M. Wurst, Tao Liu, Ruben M. Martinez, Amita Datta-Mannan and Yiqing Feng
Antibodies 2020, 9(1), 2; https://doi.org/10.3390/antib9010002

The winner (corresponding author) will receive CHF 500 and a chance to publish a paper in Antibodies in 2023.

On behalf of the assessment committee, I congratulate the winner on their accomplishments. We would like to take this opportunity to thank all the nominated research groups of the above exceptional paper for their contributions to Antibodies, and thank the Award Committee for voting and helping with this award.

Editor-in-Chief
Dr. Arne Skerra, Antibodies

Dear colleagues,

To acknowledge the continued support of our authors, we are pleased to announce the “Antibodies 2021 Best Paper Award” for research and review articles published in Antibodies from 1 January 2019 to 31 December 2019. We hope this award will encourage the publication of other high-quality papers in the journal. The award has been granted to one review article:

Antibody Structure and Function: The Basis for Engineering Therapeutics 
By Mark L. Chiu; Dennis R. Goulet; Alexey Teplyakov and Gary L. Gilliland.
Antibodies 2019, 8(4), 55; https://doi.org/10.3390/antib8040055

The winner (corresponding authors) will receive a certificate, 500 CHF and a chance to publish a paper free of charge in Antibodies in 2021, after the normal peer-review procedure.

We would like to take this opportunity to thank all our authors for their continued support.

Antibodies Editorial Office

Dear Colleagues,

We are pleased to announce that the following reviewer has been selected as the winner of the Antibodies 2020 Outstanding Reviewer Award. This award is in appreciation of the numerous timely and high-quality reviews of 2020. The winner will receive a certificate, 500 CHF and an opportunity to publish a paper free of charge in 2021.

Dr. David Vance
Wadsworth Center, NYS Department of Health, Division of Infectious Diseases, USA
Research Interest: antibodies; mAbs; phage display; epitopes; ricin; VHH; nanobody

We want to extend our congratulations to the winner for his excellent reviews and well-earned award!

The Antibodies Editorial Board and Editorial Team would like to acknowledge all reviewers who have generously dedicated their time and efforts to reviewing manuscripts submitted to Antibodies. Due to their outstanding contributions, the high scientific quality and fast article processing time of the journal are being maintained.

Antibodies Editorial Office

Dear Colleagues,

On behalf of the editorial office, I am pleased to announce the winners of the Antibodies Travel Awards for 2019: The Travel Awards Prize (800 CHF) goes to Dr. Annika Frede, Post-doctoral Fellow at the Department of Medicine, Karolinska Institute, Stockholm, Sweden (in the laboratory of Dr. Eduardo Villablanca).

Additionally, Dr. Carly May Bliss, Mr. Manuel Matos, and Mr. Ian Setliff were awarded Excellent Young Researcher certificates. Congratulations to the winners of this very competitive travel award.

The competition for the 2020 travel awards will be opened in early October 2019. Please check www.mdpi.com/journal/antibodies for more information closer to this date.

Dear Colleagues,

On behalf of the Antibodies editorial office, I am pleased to announce the winners of the 2018 Antibodies Travel Awards:

• The first Travel Awards Prize (800 CHF) goes to Carlos Castrillon, PhD student at the Institut Pasteur, Paris, France (laboratory of Dr. Pierre Bruhns). Carlos Castrillon’s research focuses on single-cell bioassays based on droplet microfluidics.
• The second Travel Awards Prize (600 CHF) goes to Veronika Chromikova, Post-doctoral fellow at Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA (laboratory of Professor Dr. Florian Krammer). Veronika Chromikova’s research deals with the recombinant production of monoclonal IgMs, using CHO DG44 and HEK 293 cell lines.
• The Third Travel Awards Prize goes to Min Shen, PhD student at Department of Chemistry, University of Connecticut, Storrs, CT, USA (laboratory of Professor Dr. James F. Rusling). Min Shen’s current research focuses on the accurate profiling of the IgE antibody repertoire in individuals exposed to allergens such as peanuts.
• Additionally, Ms. Marieke Heineke, Dr. Minkyo Song and Dr. CandaceBever were awarded Excellent Young Researcher certificates.

Congratulations to the winners of this very competitive travel award. I would like to thank the committee members for their contribution. They are Prof. Mark Cragg, Antibody and Vaccine Group, University of Southampton, Southampton, UK; Dr. Jeanette H.W. Leusen, Laboratory for Translational Immunology, University Medical Center, Utrecht, the Netherlands; Prof. Dr. Tianlei Ying, Antibody Engineering and Drug Discovery Group, Shanghai Medical College, Fudan University, Shanghai, China; Prof. Dr. Dimiter S. Dimitrov, director of Center for Antibody Therapeutics, University of Pittsburgh Medical School, Pittsburgh, PA, USA.

Dr. Dimiter Dimitrov,
Editor-in-Chief

Dear Colleagues,

Yanling Wu (Fudan University, Shanghai) and Mark Bailey (Icahn School of Medicine at Mount Sinai, New York) are the recipients of the 2017 Antibodies Travel Award for excellence in antibody research by graduate students or postdoctoral fellows; the Award will be used to participate in an antibody related conference. Both students have already coauthored several excellent articles and have conducted outstanding research in the antibody field. They plan to attend an antibody engineering and therapeutic meeting, and a vaccine meeting, respectively.

I congratulate the recipients of this year’s Award and wish them every success in their research.

I would like to thank the Selection Committee members Dr. Nathalie Scholler and Dr. R. James Christie for their valuable time in evaluating the candidates.

Dr. Dimiter Dimitrov,
Editor-in-Chief of Antibodies